Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial

[1]  C. Langner,et al.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.

[2]  D. Jonkers,et al.  Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach , 2017, Inflammatory bowel diseases.

[3]  M. Zeegers,et al.  Cohort Profile Cohort Profile : The Inflammatory Bowel Disease South Limburg Cohort ( IBDSL ) , 2015 .

[4]  M. Zeegers,et al.  Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort , 2017, The American Journal of Gastroenterology.

[5]  K. Gray,et al.  EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review. , 2016, Journal of Crohn's & colitis.

[6]  M. Dubinsky,et al.  Patient-reported Anxiety: A Possible Predictor of Pediatric Inflammatory Bowel Disease Health Care Use , 2016, Inflammatory bowel diseases.

[7]  Stephanie J. C. Taylor,et al.  Do self-management interventions in COPD patients work and which patients benefit most? An individual patient data meta-analysis , 2016, International journal of chronic obstructive pulmonary disease.

[8]  David W. Bates,et al.  Accelerating Innovation in Health IT. , 2016, The New England journal of medicine.

[9]  Steven M Bradley,et al.  Incorporating Health Status in Routine Care to Improve Health Care Value: The VA Patient Reported Health Status Assessment (PROST) System. , 2016, JAMA.

[10]  Begoña García Zapirain,et al.  Monitoring and Follow-up of Chronic Heart Failure: a Literature Review of eHealth Applications and Systems , 2016, Journal of Medical Systems.

[11]  D. Leffler,et al.  Poor Documentation of Inflammatory Bowel Disease Quality Measures in Academic, Community, and Private Practice. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  Raquel Faubel,et al.  Telemedicine in Inflammatory Bowel Disease: Opportunity Ahead. , 2016, Inflammatory bowel diseases.

[13]  L. Stassen,et al.  Disease Outcome of Ulcerative Colitis in an Era of Changing Treatment Strategies: Results from the Dutch Population-Based IBDSL Cohort. , 2015, Journal of Crohn's & colitis.

[14]  P. Munkholm,et al.  eHealth: Individualization of Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis , 2014, Inflammatory bowel diseases.

[15]  R. Fedorak,et al.  Distance management of inflammatory bowel disease: systematic review and meta-analysis. , 2014, World journal of gastroenterology.

[16]  C. Siegel,et al.  Translating improved quality of care into an improved quality of life for patients with inflammatory bowel disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  U. Siebert,et al.  Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study , 2013, European journal of gastroenterology & hepatology.

[18]  T. Dassopoulos,et al.  Quality Indicators for Inflammatory Bowel Disease: Development of Process and Outcome Measures , 2013, Inflammatory bowel diseases.

[19]  P. Munkholm,et al.  eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in Crohn's disease , 2012, Alimentary pharmacology & therapeutics.

[20]  T. Taft,et al.  The role of self‐efficacy in inflammatory bowel disease management: Preliminary validation of a disease‐specific measure , 2011, Inflammatory bowel diseases.

[21]  Johan Burisch,et al.  E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approach , 2010, Gut.

[22]  Joseph Finkelstein,et al.  Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT)* , 2010, Inflammatory bowel diseases.

[23]  P. Lakatos.  Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it? , 2009, World journal of gastroenterology.

[24]  D. Berwick,et al.  The triple aim: care, health, and cost. , 2008, Health affairs.

[25]  J Lyle Bootman,et al.  Value in health care. , 2006, Managed care interface.

[26]  E. Irvine,et al.  The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. , 1996, The American journal of gastroenterology.

[27]  A. Ekbom,et al.  Epidemiology of inflammatory bowel disease , 1992, Current opinion in gastroenterology.

[28]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[29]  H. Tilg,et al.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management , 2017, Journal of Crohn's & colitis.

[30]  L. Peyrin-Biroulet,et al.  Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases. , 2017, Gastroenterology.

[31]  J. Lennard-jones,et al.  Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.